Bupa announces appointment of Professor Melvin Samsom as a Non-Executive Director

11 April 2019 . International

Bupa today announces the appointment of Professor Melvin Samsom as a Non-Executive Director with immediate effect. This appointment brings continued clinical expertise to the Bupa Board with the imminent retirement of Professor Sir John Tooke.

Professor Samsom brings substantial international clinical and management experience from his career in gastroenterology as both a consultant and researcher, and more recently as a hospital Chief Executive at Radboud University Medical Center in the Netherlands and the Karolinska University Hospital in Sweden. He is also currently the Director of Health and Wellbeing for the Neom Project, a proposed new, futuristic city in Saudi Arabia.

Roger Davis, Chairman of Bupa said: “I would like to thank Sir John for his exceptional contribution to the Board over nearly a decade. As Bupa’s longstanding clinical NED, we have benefited from Sir John’s deep clinical expertise, as well as from his commitment to focusing on improving health outcomes for our customers. We are delighted to welcome Melvin to the Board and look forward to working with him. He brings valuable international clinical expertise from a number of different healthcare systems.”

Notes to editor

For more information contact:


Rupert Gowrley (+44 (0) 7834 624675), Mar Soro (+44 (0)7860 735902) (Corporate Affairs)


Gareth Evans (Treasury): +44 (0) 20 3314 1708

About Bupa

Bupa's purpose is helping people live longer, healthier, happier lives.

With no shareholders, our customers are our focus. We reinvest profits into providing more and better healthcare for the benefit of current and future customers.

Health insurance accounts for the major part of our business with 15.7m customers and contributes over 70% of revenue. We operate clinics, dental centres and hospitals in some markets, with 15m customers. We care for around 23,000 residents in our UK, Australia, New Zealand and Spain aged care businesses.

We directly employ around 80,000 people, principally in the UK, Australia, Spain, Poland, Chile, New Zealand, Hong Kong, Turkey, the US, Brazil, the Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.

For more information, visit www.bupa.com.